Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lowest Effective Dose of Ropivacaine for Ultrasound-Guided Supringuinal Iliofascial Space Block
ChiCTR2400092957Phase 4Not yet recruiting
- Sponsor
- Chongqing Orthopaedic Hospital of Traditional Chinese Medicine
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in patella fracture, sponsored by Chongqing Orthopaedic Hospital of Traditional Chinese Medicine. Primary endpoints: Ropivacaine 90% minimum effective concentration and Half effective volume (ED50). Planned start Dec 2024; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
patella fracture
Beyond the preview
Go deeper on ChiCTR2400092957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092957.